MET and lung adenocarcinoma: Lung adenocarcinoma cell lines, including H596 (harboring a MET exon 14 skipping mutation) and H1993 (harboring a MET amplification), and a gastric carcinoma cell line, Hs746T (harboring both a MET exon 14 skipping mutation and MET amplification), were used in this study.